alb-interferon alfa 2b
CABF656B2202
Phase 2 small_molecule completed
Quick answer
alb-interferon alfa 2b for Chronic Hepatitis C is a Phase 2 program (small_molecule) at Novartis Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Pharmaceuticals
- Indication
- Chronic Hepatitis C
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed